Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
10/1999
10/13/1999EP0948498A1 Sulfonamide compounds having 5-ht receptor activity
10/13/1999EP0948496A2 Substituted pyrimidinone and pyridone compounds and methods of use
10/13/1999EP0948495A1 Aryl and heteroaryl substituted fused pyrrole antiinflammatory agents
10/13/1999EP0948478A1 ARYL OR HETEROARYL SUBSTITUTED 3,4-DIHYDROANTHRACENE AND ARYL OR HETEROARYL SUBSTITUTED BENZO 1,2-g]-CHROM-3-ENE, BENZO 1,2-g]-THIOCHROM-3-ENE AND BENZO 1,2-g]-1,2-DIHYDROQUINOLINE DERIVATIVES HAVING RETINOID ANTAGONIST OR RETINOID INVERSE AGONIST TYPE BIOLOGICAL ACTIVITY
10/13/1999EP0948346A1 USE OF CONOTOXIN PEPTIDES ImI AND MII AS CARDIOVASCULAR AGENTS
10/13/1999EP0948335A1 Methods of treating or preventing cardiac arrhythmia
10/13/1999EP0948327A1 Antidiabetic agents
10/13/1999EP0948257A1 Triaryl substituted imidazoles, compositions containing such compounds and methods of use
10/13/1999EP0710233B1 Heteroaryl cycloalkenyl hydroxyureas
10/13/1999EP0579618B1 Pyridine- and imidazole-derived agents for cardiovascular diseases
10/13/1999EP0564592B1 Liver enriched transcription factor
10/13/1999CN1231671A Antithrombotic azacycloalkylakanoyl peptides and pseudopeptides
10/13/1999CN1231666A Tricyclic benzazepine vasopressin antagonists
10/13/1999CN1231664A Sulfonamicles and derivatives thereof that moulate the activity of endothelin
10/13/1999CN1231662A Quinazoline derivatives and pharmaceutical compositions containing them
10/13/1999CN1231659A Stable non-hygroscopic crystalline form of N-[N-N-(4-(piperidin-4-YL) butanoyl)-N-ethylglycyl] compound
10/13/1999CN1231612A Inhibition of 2,3-dihydrogen-indone to 26S and 20S prolease
10/13/1999CN1231611A Puring inhibitors of cylin dependent kinase 2 and I'kappa'beta-'alpha'
10/13/1999CN1231605A Use of sibutramine analogues to lower lipid levels
10/13/1999CN1231601A Oral delayed immediate release formulation and method of preparation therefor
10/13/1999CN1231198A Medicinal composition containing total saponin extracted from stem and leaves of American ginseng
10/13/1999CN1231176A Method for treating heart failure
10/13/1999CN1231174A Medicinal compositions for curing cardio-vascular diseases and benign prostatomegaly
10/13/1999CN1045602C Tetrahydropyrido-indole derivant and medicinal composition and pharmaceutical use thereof
10/13/1999CN1045596C Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action
10/13/1999CN1045595C Process for the preparation of the intermediates used in the synthesis of 3-aminopiperidine derivatives
10/13/1999CN1045594C Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
10/12/1999US5965744 Ortho-substituted benzoylguanidines, including composition and methods of using them
10/12/1999US5965732 Sulfonamide endothelin antagonists
10/12/1999US5965692 Anticoagulants for treatment of thromobosis and hypercoagulability in blood and tissues
10/12/1999US5965615 Hydroxyl radical scavenger
10/12/1999US5965606 Retinoid receptors, 2-fluoro-4-(2',2',4',4'-tetramethyl-8'-trifluoromethylchroman-6' -yl)carbamoyl benzoic acid for treating monocytic leukemia
10/12/1999US5965592 Acyl compounds
10/12/1999US5965580 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
10/12/1999US5965575 N-aryl piperidine compounds as 5HT1B antagonists
10/12/1999US5965564 Enantiomerically pure hydroxylated xanthine compounds
10/12/1999US5965562 Treating disorders induced by substance p and migraine headache
10/12/1999US5965555 Xanthine compounds having terminally animated alkynol side chains
10/12/1999US5965553 Anticholesterol agents, hypotriglyceridemic agents, antiatherosclerosis agents, antifungal agents, alzheimer's agents or anti-acne agents
10/12/1999US5965423 A polypeptide; diagnosis of cirrhosis, multiple sclerosis, gastrointestinal disorders, respiratory disorders, acquired immune defiency syndrome; antiarthritic/antiischemic/ antiallergens/ antiproliferactive agents
10/12/1999US5965420 A protein which stimulates cell proliferation; treatment of bone loss due to osteoporosis; treat adult respiratory disease syndrome, parkinson'disease, huntington's disease; antiarthritic/anticarcinogenic agents; antiallergens
10/12/1999US5965386 Yeast strains and modified albumins
10/12/1999US5965367 Purified bradykinin B1 receptor
10/12/1999US5965365 A human growth factor receptor binding gene; treatment and diagnosis of smooth muscle disorders; antiproliferative/ anticarcinogenic/antitumor agents
10/12/1999CA1340785C Platelet activating factor antagonists
10/07/1999WO1999050660A1 Use of ror receptors for screening substances useful for the treatment of atherosclerosis
10/07/1999WO1999050658A2 Methods and compounds for modulating nuclear receptor activity
10/07/1999WO1999050413A2 THERAPEUTIC APPLICATIONS OF MATURE FLINT (mFLINT) POLYPEPTIDES OR OPG3, A MEMBER OF THE TNF RECEPTOR SUPERFAMILY
10/07/1999WO1999050296A1 Treatment and prevention of vascular disease
10/07/1999WO1999050278A1 Compositions and methods for the identification of lung tumor cells
10/07/1999WO1999050263A1 Quinolones as serine protease inhibitors
10/07/1999WO1999050257A1 Benzoxazinones/benzothiazinones as serine protease inhibitors
10/07/1999WO1999050249A2 Pyrimidines and triazines as integrin antagonists
10/07/1999WO1999050239A2 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
10/07/1999WO1999050225A1 Aminocyclohexyl ether compounds and uses thereof
10/07/1999WO1999049909A2 Revascularization apparatus having coaxial channeling and injecting means
10/07/1999WO1999049885A2 The use of isolated domains of type iv collagen to modify cell and tissue interactions
10/07/1999WO1999049884A1 A method for the prevention of a patient's fibroproliferative vasculopathy
10/07/1999WO1999049880A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999WO1999049877A2 Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
10/07/1999WO1999049864A1 Indole-2,3-dione-3-oxime derivatives for therapeutic use
10/07/1999WO1999043310A3 20-hete antagonists and agonists
10/07/1999WO1999042456A3 Novel compounds and their use as positive ampa receptor modulators
10/07/1999WO1999040197A3 Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
10/07/1999WO1999030720A9 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha
10/07/1999WO1999018930A3 Pharmaceutical preparations
10/07/1999CA2333927A1 Pyrimidines and triazines as integrin antagonists
10/07/1999CA2326588A1 Methods for treating an ischemic disorder and improving stroke outcome
10/07/1999CA2326576A1 Indole-2,3-dione-3-oxime derivatives for therapeutic use
10/07/1999CA2324517A1 Therapeutic applications of mature flint (mflint) polypeptides or opg3, a member of the tnf receptor superfamily
10/07/1999CA2324476A1 Treatment and prevention of vascular disease
10/07/1999CA2324060A1 Methods and compounds for modulating nuclear receptor activity
10/07/1999CA2323833A1 Compositions and methods for the identification of lung tumor cells
10/07/1999CA2323748A1 A method for the prevention of a patient's fibroproliferative vasculopathy
10/07/1999CA2319551A1 Benzoxazinones/benzothiazinones as serine protease inhibitors
10/07/1999CA2312953A1 Quinolones as serine protease inhibitors
10/06/1999EP0947506A1 2-Aza-bicyclo[2.2.1]heptane derivatives and their use as rotamase inhibitors
10/06/1999EP0947496A1 Bicyclic aromatic compounds and their use in human and veterinary medicine as well as in cosmetology
10/06/1999EP0946722A1 Human apoptosis-related calcium-binding protein
10/06/1999EP0946587A2 New amide compounds
10/06/1999EP0946562A1 PYRROLO 3,4-$i(D)]PYRIMIDINONE DERIVATIVES AND THEIR USE AS MEDICAMENTS
10/06/1999EP0946561A1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments
10/06/1999EP0946557A1 A-1-adenosine receptor antagonists
10/06/1999EP0946552A1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/06/1999EP0946550A1 PREPARATION OF 1S- 1a,2b,3b,4a(S*)]]-4- 7- 1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO 4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE
10/06/1999EP0946546A1 Pyridin-2-yl-methylamine derivatives, method of preparing and application as medicine
10/06/1999EP0946542A1 Indane or dihydroindole derivatives
10/06/1999EP0946541A1 Quinolines and their therapeutic use
10/06/1999EP0946538A1 Indane or dihydroindole derivatives
10/06/1999EP0946528A2 OXYGEN OR SULFUR CONTAINING 5-MEMBERED HETEROAROMATICS AS FACTOR Xa INHIBITORS
10/06/1999EP0946524A1 Heterocyclic carboxylic acid derivatives, the production and use thereof as endothelin receptor antagonists
10/06/1999EP0946519A1 Benzamide derivatives having a vasopressin antagonistic activity
10/06/1999EP0946512A1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/06/1999EP0946509A1 Novel heterocyclically substituted benzamides and their use in fighting diseases
10/06/1999EP0946503A1 Nitromethylthiobenzene derivatives as inhibitors of aldose reductase
10/06/1999EP0946502A1 Sulfonamide interleukin-beta converting enzyme inhibitors
10/06/1999EP0946205A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
10/06/1999EP0946196A1 Method for treating symptoms of diabetes
10/06/1999EP0946190A1 Methods and compositions for stimulating neurite growth using compounds with affinity for fkbp12 in combination with neurotrophic factors
10/06/1999EP0946185A1 PHARMACEUTICAL COMPOSITION COMPRISING A COMPOUND HAVING ANTI-Xa ACTIVITY AND A PLATELET AGGREGATION ANTAGONIST COMPOUND
1 ... 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 ... 1595